Key statistics
As of last trade, KALA BIO Inc (27F0:FRA) traded at 4.79, 13.30% above the 52 week low of 4.22 set on Jun 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.79 |
---|---|
High | 4.79 |
Low | 4.79 |
Bid | 4.83 |
Offer | 4.93 |
Previous close | 4.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 4.61m |
Free float | 4.37m |
P/E (TTM) | -- |
Market cap | 24.65m USD |
EPS (TTM) | -13.95 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 07:44 BST.
More ▼
Announcements
- KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- KALA BIO Announces $12,500,000 Private Placement
- KALA BIO to Present at Jefferies Global Healthcare Conference
- KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
- KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
More ▼